Vista Pharmaceuticals Limited (VISTAPH.BO)
INR 11.08
(2.12%)
INR 11.08
(2.12%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -10.14 Million INR | 7.64% |
| 2022 | -46.29 Million INR | -153.4% |
| 2021 | -18.26 Million INR | 25.66% |
| 2020 | -24.57 Million INR | 57.77% |
| 2019 | -58.18 Million INR | -1277.68% |
| 2018 | 4.94 Million INR | -87.66% |
| 2017 | 40.05 Million INR | 255.58% |
| 2016 | 11.26 Million INR | 34.35% |
| 2015 | 8.38 Million INR | -33.28% |
| 2014 | 12.56 Million INR | 165.52% |
| 2013 | 4.73 Million INR | 177.69% |
| 2012 | 1.7 Million INR | 111.06% |
| 2011 | -15.41 Million INR | -427.44% |
| 2010 | -2.92 Million INR | 77.8% |
| 2009 | -13.16 Million INR | -30.13% |
| 2008 | -10.11 Million INR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -9.59 Million INR | -364.27% |
| 2023 Q3 | -19.15 Million INR | -73.21% |
| 2023 FY | -42.75 Million INR | 7.64% |
| 2023 Q4 | 974 Thousand INR | 105.08% |
| 2023 Q2 | -11.06 Million INR | -1.07% |
| 2023 Q1 | -10.94 Million INR | 55.97% |
| 2022 Q3 | -4.88 Million INR | -61.59% |
| 2022 FY | -46.29 Million INR | -153.4% |
| 2022 Q4 | -24.85 Million INR | -408.55% |
| 2022 Q2 | -3.02 Million INR | 14.91% |
| 2022 Q1 | -3.55 Million INR | 23.61% |
| 2021 Q2 | -4.59 Million INR | 22.34% |
| 2021 FY | -18.26 Million INR | 25.66% |
| 2021 Q4 | -4.65 Million INR | -49.5% |
| 2021 Q1 | -5.91 Million INR | 33.35% |
| 2021 Q3 | -3.11 Million INR | 32.18% |
| 2020 Q4 | -8.86 Million INR | -112.03% |
| 2020 FY | -24.57 Million INR | 57.77% |
| 2020 Q1 | -2.86 Million INR | 92.91% |
| 2020 Q2 | -6.68 Million INR | -133.23% |
| 2020 Q3 | -4.18 Million INR | 37.48% |
| 2019 Q3 | 3.92 Million INR | -30.15% |
| 2019 Q4 | -40.42 Million INR | -1129.41% |
| 2019 FY | -58.18 Million INR | -1277.68% |
| 2019 Q1 | 5.15 Million INR | 12.82% |
| 2019 Q2 | 5.62 Million INR | 9.02% |
| 2018 Q4 | 4.57 Million INR | -18.26% |
| 2018 FY | 4.94 Million INR | -87.66% |
| 2018 Q2 | 8.7 Million INR | 5.86% |
| 2018 Q1 | 8.22 Million INR | -21.38% |
| 2018 Q3 | 5.59 Million INR | -35.75% |
| 2017 Q2 | 9.06 Million INR | 62.52% |
| 2017 FY | 40.05 Million INR | 255.58% |
| 2017 Q4 | 10.45 Million INR | -5.0% |
| 2017 Q3 | 11 Million INR | 21.44% |
| 2017 Q1 | 5.57 Million INR | 453.82% |
| 2016 Q1 | 2.98 Million INR | -66.55% |
| 2016 Q4 | 1 Million INR | -76.04% |
| 2016 Q3 | 4.2 Million INR | 31.93% |
| 2016 Q2 | 3.18 Million INR | 6.56% |
| 2016 FY | 11.26 Million INR | 34.35% |
| 2015 Q4 | 8.93 Million INR | 172.94% |
| 2015 FY | 8.38 Million INR | -33.28% |
| 2015 Q1 | -4.93 Million INR | -287.85% |
| 2015 Q2 | -12.01 Million INR | -143.4% |
| 2015 Q3 | -12.25 Million INR | -1.99% |
| 2014 Q4 | 2.62 Million INR | -62.04% |
| 2014 FY | 12.56 Million INR | 165.52% |
| 2014 Q1 | 955 Thousand INR | -92.76% |
| 2014 Q2 | 2.06 Million INR | 116.13% |
| 2014 Q3 | 6.92 Million INR | 235.27% |
| 2013 Q1 | -3.08 Million INR | -635.51% |
| 2013 FY | 4.73 Million INR | 177.69% |
| 2013 Q4 | 13.19 Million INR | 340.49% |
| 2013 Q3 | -5.48 Million INR | -3857.53% |
| 2013 Q2 | 146 Thousand INR | 104.74% |
| 2012 Q1 | 449 Thousand INR | 128.06% |
| 2012 FY | 1.7 Million INR | 111.06% |
| 2012 Q4 | 575.15 Thousand INR | 299.41% |
| 2012 Q3 | 144 Thousand INR | -85.31% |
| 2012 Q2 | 980 Thousand INR | 118.26% |
| 2011 FY | -15.41 Million INR | -427.44% |
| 2011 Q3 | -4.48 Million INR | 0.0% |
| 2011 Q4 | -1.6 Million INR | 64.35% |
| 2010 FY | -2.92 Million INR | 77.8% |
| 2010 Q4 | 1.54 Million INR | 0.0% |
| 2009 Q4 | -3.64 Million INR | 0.0% |
| 2009 FY | -13.16 Million INR | -30.13% |
| 2008 Q4 | -4.53 Million INR | 0.0% |
| 2008 FY | -10.11 Million INR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 531.8 Thousand INR | 2008.048% |
| Sastasundar Ventures Limited | -229.64 Million INR | 95.581% |
| KIMIA BIOSCIENCES LIMITED | -37.75 Million INR | 73.126% |
| SHELTER PHARMA LIMITED | 98.67 Million INR | 110.284% |
| Vasundhara Rasayans Limited | 61.27 Million INR | 116.56% |
| Sunil Healthcare Limited | -19.98 Million INR | 49.217% |
| Chemo Pharma Laboratories Limited | 16.43 Million INR | 161.74% |
| MedPlus Health Services Limited | 1.31 Billion INR | 100.769% |
| Zenith Healthcare Limited | 196 Thousand INR | 5277.041% |
| Patidar Buildcon Limited | -1.83 Million INR | -452.669% |
| Sanjivani Paranteral Limited. | 64.47 Million INR | 115.739% |
| Roopa Industries Limited | 48.05 Million INR | 121.115% |
| Smruthi Organics Limited | - INR | Infinity% |
| Trident Lifeline Limited | 72.21 Million INR | 114.052% |
| Bacil Pharma Limited | -1.89 Million INR | -435.648% |
| Pharmaids Pharmaceuticals Limited | -149.31 Million INR | 93.204% |
| Gujarat Terce Laboratories Limited | 8.99 Million INR | 212.87% |
| Bharat Immunologicals & Biologicals Corporation Limited | -160.07 Million INR | 93.661% |
| Sandu Pharmaceuticals Limited | 17.12 Million INR | 159.253% |
| PANJON LTD. | - INR | Infinity% |
| Tyche Industries Limited | 111.22 Million INR | 109.123% |
| Trimurthi Limited | -6.14 Million INR | -65.179% |
| TIAAN CONSUMER LIMITED | -17.91 Million INR | 43.367% |
| Anuh Pharma Limited | 682.19 Million INR | 101.487% |
| Crestchem Limited | 27.25 Million INR | 137.229% |
| Emmessar Biotech & Nutrition Limited | -11.75 Million INR | 13.679% |
| Zenlabs Ethica Limited | 89.27 Million INR | 111.366% |
| Vikram Thermo (India) Limited | 339.45 Million INR | 102.989% |
| ANG Lifesciences India Limited | 12.8 Million INR | 179.242% |
| Parmax Pharma Limited | 3.75 Million INR | 370.259% |
| Fredun Pharmaceuticals Limited | 364.25 Million INR | 102.786% |
| Deccan Health Care Limited | 185.32 Million INR | 105.475% |
| Shukra Pharmaceuticals Limited | 236.26 Million INR | 104.295% |
| Norris Medicines Limited | 11.15 Million INR | 190.946% |
| SUDARSHAN PHARMA INDUSTRIES LI | 215.67 Million INR | 104.705% |
| Veerhealth Care Limited | 34.19 Million INR | 129.677% |
| Makers Laboratories Limited | -34.91 Million INR | 70.934% |
| Lactose (India) Limited | 137.78 Million INR | 107.364% |
| OXYGENTA PHARMACEUTICAL LIMITE | -123.57 Million INR | 91.789% |
| Ambalal Sarabhai Enterprises Limited | 436.8 Million INR | 102.323% |
| Mercury Laboratories Limited | 62.14 Million INR | 116.327% |
| Gennex Laboratories Limited | 146.61 Million INR | 106.921% |
| PRAVEG LIMITED | 185.06 Million INR | 105.483% |
| Denis Chem Lab Limited | 142.87 Million INR | 107.102% |
| Kwality Pharmaceuticals Limited | 500.7 Million INR | 102.027% |
| Jenburkt Pharmaceuticals Limited | 669.04 Million INR | 101.517% |
| Colinz Laboratories Limited | 14.64 Million INR | 169.296% |
| Godavari Drugs Limited | -67.67 Million INR | 85.005% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | -2399.261% |
| Zenotech Laboratories Limited | 242.37 Million INR | 104.186% |
| Panchsheel Organics Limited | 288.28 Million INR | 103.52% |
| Shree Ganesh Remedies Limited | 572.48 Million INR | 101.772% |
| Vivanza Biosciences Limited | 14.83 Million INR | 168.413% |
| Phaarmasia Limited | - INR | Infinity% |
| Bharat Parenterals Limited | 733.49 Million INR | 101.383% |
| Medi-Caps Limited | -17.21 Million INR | 41.04% |
| DECIPHER LABS LIMITED | 53.74 Million INR | 118.882% |
| Gujarat Themis Biosyn Limited | 853.97 Million INR | 101.188% |
| BDH Industries Limited | 169.01 Million INR | 106.004% |
| Coral Laboratories Limited | 142.63 Million INR | 107.114% |
| Concord Drugs Limited | 24.87 Million INR | 140.797% |
| Beryl Drugs Limited | 14.73 Million INR | 168.877% |
| Evoq Remedies Limited | 42.91 Million INR | 123.643% |
| Add-Shop E-Retail Limited | 77.57 Million INR | 113.081% |
| Transchem Limited | -17.43 Million INR | 41.814% |
| Ishita Drugs and Industries Limited | 7.96 Million INR | 227.347% |
| Parnax Lab Limited | 166.84 Million INR | 106.082% |
| Source Natural Foods and Herbal Supplements Limited | 34.15 Million INR | 129.709% |
| Kerala Ayurveda Limited | 48.04 Million INR | 121.119% |
| Cian Healthcare Limited | 53.96 Million INR | 118.802% |
| Trinity League India Limited | 1.17 Million INR | 965.047% |
| Syschem (India) Limited | 504.91 Million INR | 102.01% |
| KOBO BIOTECH LIMITED | -2.48 Million INR | -309.153% |
| Natural Capsules Limited | 112.4 Million INR | 109.028% |
| Auro Laboratories Limited | 95.77 Million INR | 110.595% |